In 2025, Sino Biopharmaceutical disclosed key data related to its energy management practices, providing transparency into its operational energy use in line with recognized sustainability reporting frameworks.
Sino Biopharmaceutical disclosed progress toward renewable energy adoption, highlighting the share of total energy sourced from renewable versus non-renewable sources.
| Metric (GJ) | 2025 | 2024 | 2023 | 2022 - 2017 |
|---|---|---|---|---|
Total Energy Consumption | 1,674,407a | 1,741,597a | 1,724,751a | |
Non-Renewable Energy Consumption | 1,478,337a | 1,709,652a | 1,697,736a | |
Renewable Energy Consumption | 196,071a | 31,946a | 27,015a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Sino Biopharmaceutical’s data sources below and access millions more through our Disclosure Search.
In 2025, Sino Biopharmaceutical consumed a total of 1.67 million Gigajoules of energy across its operations. Of this total, 11.71% was sourced from renewable energy, either derived from natural resources like biofuels, biomass, or biogas, or generated using renewable technologies such as solar or wind power. The remaining 88.29% was classified as non-renewable energy, coming from fossil-based fuels such as coal, natural gas, or crude oil, or from non-renewable generation technologies like nuclear power.a
In 2025, Sino Biopharmaceutical consumed a total of 1.67 million Gigajoules of energy, of which 11.71% was derived from renewable sources, including biofuels, biomass, biogas, solar, and wind power.a
This low level of renewable energy use highlights a heavy reliance on fossil fuels or other non-renewable sources, suggesting that Sino Biopharmaceutical has considerable room to improve its energy sustainability strategy.
Since 2023, Sino Biopharmaceutical's total energy consumption decreased by 2.92%, including a further 3.86% drop in 2025, highlighting a continued decline in energy use.a
Over the same period, the share of renewable energy in Sino Biopharmaceutical's consumption increased by 647.6%, including a 538.39% increase in 2025, showing consistent progress in clean energy adoption.a
Overall, Sino Biopharmaceutical has reduced its total energy consumption while steadily increasing its use of renewables, reflecting a strong commitment to reducing its energy-related environmental footprint.